Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Accu Bio-Chem Laboratories LLC
WARNING LETTER
•Accu Bio-Chem Laboratories LLC•August 31, 2021

Accu Bio-Chem Laboratories LLC – FDA Warning Letter, Aug 31, 2021

Record Details

The FDA inspected Accu Bio-Chem Laboratories, a contract testing laboratory, from August 24-31, 2021, and found significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals (21 CFR parts 210 and 211). The drug products tested by Accu Bio-Chem are considered adulterated.

Key violations include: 1. **Inadequate OOS Investigations (21 CFR 211.192):** The firm failed to thoroughly investigate out-of-specification (OOS) results, often retesting new preparations without proper investigation. Their OOS procedure lacked instructions for root cause determination and allowed scientifically unjustified invalidation of results. The FDA requires a retrospective review of all invalidated OOS results for the last three years, including scientific justification and client notifications, and a comprehensive remediation plan for OOS investigation systems. 2. **Failure to Validate Test Methods (21 CFR 211.165(e)):** The firm did not perform method verification to ensure chemical and microbiological test methods were suitable for their intended use across different drug products and formulations. The FDA requires an independent assessment of all chemical and microbiological drug test methods, a plan and timeline for verification/validation, and updated procedures. 3. **Inadequate Computer System Controls (21 CFR 211.68(b)):** Electronic data systems lacked appropriate controls to

Company
Accu Bio-Chem Laboratories LLC
Inspection date
August 31, 2021
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations IV
Person
  • Lance M. De Souza (Director - Compliance Branch)
View Company Profile

ID · 737a7305-f3ca-4555-badd-cab823004269

Violation Codes7
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.19221 CFR 211.165(e)21 CFR 211.68(b)FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Accu Bio-Chem Laboratories LLC
  • 483 - 2023-02-08February 8, 2023
  • 483 - 2021-08-31August 31, 2021
  • 483 - 2015-10-29October 29, 2015
  • EIR - 2015-10-29October 29, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Accu Bio-Chem Laboratories LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.